Cocrystal Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Cocrystal Pharma has a total shareholder equity of $12.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $16.2M and $3.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$13.02m |
| Equity | US$12.70m |
| Total liabilities | US$3.53m |
| Total assets | US$16.23m |
Recent financial health updates
Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation
Oct 18
Cocrystal Pharma (NASDAQ:COCP) Is In A Good Position To Deliver On Growth Plans
Aug 14We're Not Very Worried About Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate
Mar 19Companies Like Cocrystal Pharma (NASDAQ:COCP) Are In A Position To Invest In Growth
Nov 19Recent updates
Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation
Oct 18Cocrystal selects its antiviral drug candidate to develop as a treatment for COVID-19
Oct 11Cocrystal Pharma GAAP EPS of -$0.25 misses by $0.21
Aug 15Cocrystal Pharma (NASDAQ:COCP) Is In A Good Position To Deliver On Growth Plans
Aug 14Cocrystal engages Open Orphan to conduct mid-stage trial of oral influenza drug in UK
Aug 08We're Not Very Worried About Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate
Mar 19Companies Like Cocrystal Pharma (NASDAQ:COCP) Are In A Position To Invest In Growth
Nov 19We Think Cocrystal Pharma (NASDAQ:COCP) Can Afford To Drive Business Growth
Aug 06Cocrystal’s soars 11% as CDI-45205 shows excellent antiviral activity against SARS-CoV-2 and variants
Jun 14We Think Cocrystal Pharma (NASDAQ:COCP) Needs To Drive Business Growth Carefully
May 05Cocrystal Pharma updates on COVID-19 antiviral development programs
May 03Investors Who Bought Cocrystal Pharma (NASDAQ:COCP) Shares A Year Ago Are Now Up 94%
Mar 13What Is The Ownership Structure Like For Cocrystal Pharma, Inc. (NASDAQ:COCP)?
Jan 24Cocrystal sees 2021 cash burn of $800k a month
Jan 11Cocrystal Pharma to test CDI-45205 against coronaviruses
Dec 22Is Cocrystal Pharma (NASDAQ:COCP) In A Good Position To Invest In Growth?
Dec 20
Financial Position Analysis
Short Term Liabilities: COCP's short term assets ($14.3M) exceed its short term liabilities ($1.9M).
Long Term Liabilities: COCP's short term assets ($14.3M) exceed its long term liabilities ($1.6M).
Debt to Equity History and Analysis
Debt Level: COCP is debt free.
Reducing Debt: COCP had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: COCP has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: COCP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 24.5% each year